A Geriatric Oncology Collaborative Care Intervention for Older Adults With

Status Completed

Clinical Trial Summary

The purpose of this research study is to develop a geriatric oncology collaborative care intervention to enhance the quality of life, symptom burden, and functional outcomes of older adults with advanced gastrointestinal (GI) and genitourinary (GU) cancers.

Clinical Trial Description

Cancer disproportionately affects older adults, and the number of older adults with cancer is expected to grow as the population ages. Older adults with advanced cancer often possess a distinct set of medical and psycho-social issues that makes caring for the geriatric oncology population challenging for oncologists. Currently, a critical knowledge gap exists regarding how best to deliver comprehensive cancer care targeting the unique geriatric and palliative care needs of these individuals. The investigators propose to develop a geriatric oncology collaborative care intervention to improve supportive care outcomes for older adults with advanced gastrointestinal (GI) and genitourinary (GU) cancer. GI and GU cancers are among the leading causes of cancer death in the geriatric cancer population, and patients with advanced GI and GU cancers experience a high symptom burden. The intervention will entail visits with an oncology advanced practice nurse trained to address patients' unique needs, who will meet regularly with a supervising team of geriatric, palliative care, social work, and pharmacy clinicians for feedback and iterative reevaluation of the care plan. Using nurses who are already integrated into the oncology setting represents a scalable model that addresses the workforce shortage of geriatric and palliative care clinicians. The investigators used conceptual models for collaborative care and geriatric interventions to develop an initial intervention framework, and prior research to develop a preliminary intervention manual. In Aim 1, the investigators will refine and finalize both the intervention and the intervention manual based on qualitative data from patients, caregivers, and clinicians to ensure the intervention targets the unique needs of older adults with advanced cancer. In Aim 2, the investigators will modify the intervention and study methods with an open pilot study (n=10). In Aim 3, the investigators will conduct a pilot randomized trial (n=75) to assess the feasibility and preliminary efficacy of the geriatric oncology collaborative care intervention for improving patients' QOL, symptom burden, and functional outcomes. ;

Study Design

Related Conditions & MeSH terms

Other Cancer

Clinical Trial Details

NCT number	NCT03721926
Study type	Interventional
Source	Massachusetts General Hospital
Contact
Status	Completed
Phase	N/A
Start date	February 14, 2019
Completion date	March 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04340024` - Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Active, not recruiting	`NCT03609177` - Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly	N/A
Active, not recruiting	`NCT04591431` - The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy	Phase 2
Recruiting	`NCT06103669` - Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)	N/A
Recruiting	`NCT04585750` - The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)	Phase 1/Phase 2
Recruiting	`NCT03160274` - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Completed	`NCT03736746` - Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals	N/A
Completed	`NCT03638453` - Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention	N/A
Recruiting	`NCT06397651` - A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care	N/A
Active, not recruiting	`NCT03850912` - Symptom Management Implementation of Patient Reported Outcomes in Oncology	N/A
Completed	`NCT03392090` - SHARE (Sharing Goals and Preferences) Study	N/A
Completed	`NCT03244826` - Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation	N/A
Recruiting	`NCT03517332` - Circulating Tumor DNA Exposure in Peripheral Blood
Active, not recruiting	`NCT03967379` - Multimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors	N/A
Completed	`NCT05176860` - Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy	N/A
Active, not recruiting	`NCT03674047` - Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)	Phase 2
Active, not recruiting	`NCT03752268` - Development of an Intervention to Enhance Cancer Pain Management	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms